Seattle, WA, United States of America

Jean Campbell

USPTO Granted Patents = 2 


Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jean Campbell: Innovator in Immunomodulatory Protein Expression

Introduction

Jean Campbell is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of plasmid constructs for protein expression and electroporation techniques. With a total of 2 patents, her work is paving the way for advancements in therapeutic applications.

Latest Patents

Jean Campbell's latest patents include "Plasmid constructs for heterologous protein expression and methods of use." This patent provides plasmid vector constructs that encode multiple immunomodulatory proteins, allowing for the expression of each protein using appropriate promoters and translation modifiers. The constructs can also incorporate additional immunomodulatory proteins and genetic adjuvants containing shared tumor antigens, enhancing their therapeutic potential and enabling tracking of treatment.

Another notable patent is "Systems and methods for improved tissue-sensing based electroporation." This invention introduces an adaptive control method for optimizing electroporation (EP) pulse parameters during the treatment of cells or tissue. The system processes data from current and voltage measurements to separate desirable data from undesirable data, ultimately optimizing EP pulsing parameters for improved therapeutic outcomes.

Career Highlights

Jean Campbell is currently associated with Oncosec Medical Incorporated, where she continues to innovate in the field of medical technology. Her work focuses on enhancing the efficacy of cancer treatments through advanced biotechnological methods.

Collaborations

Throughout her career, Jean has collaborated with notable colleagues, including Robert H. Pierce and Arya Bahrami. These collaborations have further enriched her research and development efforts in the biotechnology sector.

Conclusion

Jean Campbell's contributions to immunomodulatory protein expression and electroporation techniques highlight her role as a leading inventor in biotechnology. Her innovative patents and ongoing work at Oncosec Medical Incorporated are set to make a significant impact in the field of cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…